Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BUDA
BUDA logo

BUDA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
9.075
Open
8.800
VWAP
8.72
Vol
10.16K
Mkt Cap
112.23M
Low
8.155
Amount
88.56K
EV/EBITDA(TTM)
--
Total Shares
12.57M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).
Show More

Events Timeline

(ET)
2026-05-26
07:10:00
Buda Juice Dual Lists on NYSE Texas Effective May 26, 2026
select
2026-05-13 (ET)
2026-05-13
07:10:00
Buda Juice Reports Q1 Adjusted EPS of 5 Cents, Revenue of $3.5M
select
2026-05-11 (ET)
2026-05-11
07:00:00
Buda Juice Launches New Drink in 246 Walmart Stores
select
2026-03-26 (ET)
2026-03-26
07:10:00
Buda Juice Reports FY25 Revenue of $12.6M
select
2026-01-22 (ET)
2026-01-22
07:10:00
Buda Juice IPO Completed with Additional 399,999 Shares Issued
select
2026-01-12 (ET)
2026-01-12
11:20:00
Aktis Oncology Shares Surge Over 5% on First Trading Day
select
2026-01-08 (ET)
2026-01-08
11:50:00
Buda Juice Prices IPO at $7.50 per Share
select
2026-01-07 (ET)
2026-01-07
17:30:00
MDB Capital Prices Deal at $7.50
select

News

seekingalpha
9.5
05-13seekingalpha
Buda Juice Q1 Earnings Beat Expectations with $3.5M Revenue
  • Earnings Highlights: Buda Juice reported a Q1 non-GAAP EPS of $0.05 with revenues of $3.5 million, reflecting a 16.7% year-over-year increase and exceeding market expectations by $0.3 million, indicating strong performance and growth potential in the market.
  • Adjusted EBITDA: The company achieved an adjusted EBITDA of $0.8 million, demonstrating effective cost control alongside revenue growth, which enhances investor confidence in its future development prospects.
  • Free Cash Flow: Buda Juice generated free cash flow of $1.1 million, indicating robust cash generation from operations that can support its expansion strategy and future investment plans, further solidifying its market position.
  • Expansion Strategy: The positive financial results provide strong support for Buda Juice's expansion strategy, which is expected to drive greater market share and brand influence in the competitive beverage industry.
Newsfilter
9.5
04-30Newsfilter
Buda Juice to Host Q1 2026 Earnings Call
  • Earnings Call Announcement: Buda Juice will host a conference call on May 13, 2026, at 11:00 a.m. Eastern Time to discuss its financial and operational results for Q1 2026, indicating the company's commitment to transparency and investor communication.
  • Live Webcast Details: The call will be available via a live webcast on the company's Investor Relations page, providing convenient access for investors to stay updated on the latest developments, thereby enhancing investor engagement.
  • Cold Chain Infrastructure Advantage: Buda Juice's proprietary cold chain platform ensures an 8 to 12-day shelf life for its products, preserving freshness and nutrient quality, which highlights the company's competitive edge and innovation in the fresh juice market.
  • Market Positioning and Strategy: As the pioneer of the Ultra Fresh™ category, Buda Juice enables retailers to offer ready-to-drink products without additional infrastructure, meeting consumer demand for fresh, healthy beverages and further solidifying its leadership position in the market.
seekingalpha
8.5
03-26seekingalpha
Buda Juice Reports Strong FY Results with $12.61M Revenue
  • Financial Highlights: Buda Juice, Inc. reported a FY GAAP EPS of $0.20 and revenue of $12.61 million, reflecting an 11.9% year-over-year growth, indicating strong performance and growth potential in the cold chain market.
  • Adjusted EBITDA: The company reported an adjusted EBITDA of $3.8 million, showcasing improved operational efficiency, which enhances investor confidence in its profitability.
  • Free Cash Flow: Buda Juice generated free cash flow of $3.0 million, demonstrating robust capital management that provides ample funding for future expansion and investments.
  • IPO Expectations: Buda Juice priced its initial public offering at $20 million, with positive market response, which is expected to further boost the company's market share and brand influence in the cold chain industry.
renaissancecapital
8.5
02-04renaissancecapital
2026 IPO Market Starts Steadily with $2.6 Billion Raised
  • IPO Market Performance: In January 2026, nine IPOs raised a total of $2.6 billion, although a backlog of startups indicated IPO plans, the overall deal count and proceeds fell below the ten-year average, reflecting cautious market sentiment.
  • Sector Dynamics: The industrial sector's EquipmentShare.com led with $747 million raised, surging 33% on its first day, indicating strong investor demand for fast-growing companies viewed as resistant to AI disruption.
  • SPAC Issuance Surge: January saw SPAC issuance reach a four-year high with 25 blank check deals raising $5.2 billion, providing hundreds of pre-IPO companies with an alternative path to public markets, reflecting growing interest in emerging technology firms.
  • Active IPO Pipeline: By the end of January, the IPO pipeline included 216 companies seeking to raise approximately $12.4 billion, with 130 having filed or updated within the last 90 days, demonstrating ongoing market interest in new public offerings.
renaissancecapital
8.5
02-04renaissancecapital
2026 IPO Market Starts Steadily with $2.6 Billion Raised
  • IPO Market Performance: In January 2026, nine IPOs raised a total of $2.6 billion, reflecting a cautious market sentiment as this figure fell short of the ten-year average, particularly after the volatility experienced in Q4 2025.
  • Sector Dynamics: The industrial sector led the month’s largest IPOs, with EquipmentShare.com raising $747 million, highlighting investor preference for fast-growing companies perceived as resilient to AI disruption.
  • Emerging Trends: The fintech and biotech sectors showed signs of recovery at the start of 2026, notably with fintech PicPay becoming the first Brazilian IPO in four years, raising $434 million, although its shares fell 5% post-IPO.
  • SPAC Activity: January saw SPAC issuance reach a four-year high with 25 deals raising $5.2 billion, indicating growing interest in pre-IPO companies opting for SPAC mergers, despite overall IPO activity remaining below 2021 peaks.
renaissancecapital
8.5
01-10renaissancecapital
Aktis Oncology Prices Upsized IPO at $318 Million, Targets Solid Tumors
  • Successful Financing: Aktis Oncology priced its upsized IPO at $318 million, achieving a market cap of $1 billion, marking the first significant deal of 2026 and demonstrating strong market interest in its radiopharmaceuticals targeting solid tumors.
  • Technological Edge: The company's alpha-emitting radiopharmaceuticals have shown superior efficacy in preclinical studies compared to Padcev, although it faces risks due to its early-stage pipeline, yet its unique treatment approach may attract investor attention.
  • Market Performance: Aktis saw a 24% increase in its stock price during its first week of trading, reflecting investor recognition of its potential market value and providing a solid foundation for future financing and R&D efforts.
  • Industry Outlook: With the rising demand for targeted therapies, Aktis's successful IPO not only enhances its visibility in the biotech sector but may also stimulate financing activities for similar companies, fostering growth across the industry.

Valuation Metrics

The current forward P/E ratio for Buda Juice Inc (BUDA.A) is 0.00, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Buda Juice Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
Current PE
0.00
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
145.28
Current EV/EBITDA
22.29
Overvalued EV/EBITDA
427.11
Undervalued EV/EBITDA
-136.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
898.55
Current PS
5.04
Overvalued PS
2993.60
Undervalued PS
-1196.50

Financials

AI Analysis
Annual
Quarterly

Whales Holding BUDA

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Buda Juice Inc (BUDA) stock price today?

The current price of BUDA is 8.931 USD — it has increased 5.07

What is Buda Juice Inc (BUDA)'s business?

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).

What is the price predicton of BUDA Stock?

Wall Street analysts forecast BUDA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUDA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Buda Juice Inc (BUDA)'s revenue for the last quarter?

Buda Juice Inc revenue for the last quarter amounts to 3.51M USD, decreased

What is Buda Juice Inc (BUDA)'s earnings per share (EPS) for the last quarter?

Buda Juice Inc. EPS for the last quarter amounts to 0.03 USD, decreased

How many employees does Buda Juice Inc (BUDA). have?

Buda Juice Inc (BUDA) has 39 emplpoyees as of June 01 2026.

What is Buda Juice Inc (BUDA) market cap?

Today BUDA has the market capitalization of 112.23M USD.